XM does not provide services to residents of the United States of America.

Assa Abloy, Kering, L'Oréal



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EUROPE RESEARCH ROUNDUP-Assa Abloy, Kering, L'Oréal</title></head><body>

Oct 24 (Reuters) -Securities analysts revised their ratings and price targets on several European companies including Assa Abloy, Kering and L'Oréal, on Thursday.


HIGHLIGHTS

* Assa Abloy ASSAb.ST: Deutsche Bank raises target price to SEK 305 from SEK 300

* Barratt Redrow Plc BTRW.L: Morgan Stanley cuts target price to 580p from 600p

* Dowlais Group Plc DWL.L: Citigroup raises to neutral from sell

* Kering PRTP.PA: JP Morgan cuts target price to EUR 220 from EUR 265

* L'Oréal SA OREP.PA: Barclays cuts target price to EUR 442 from EUR 479

Following is a summary of research actions on European companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* Air Liquide AIRP.PA: Citigroup cuts target price to EUR 200 from EUR 201

* Akzo Nobel NV AKZO.AS: HSBC raises target price to EUR 62 from EUR 57

* Allfunds Group Plc ALLFG.AS: Morgan Stanley raises PT to EUR 7.7 from EUR 7.6

* Assa Abloy ASSAb.ST: Deutsche Bank raises target price to SEK 305 from SEK 300

* Atlas Copco AB ATCOa.ST: Deutsche Bank cuts target price to SEK 178 from SEK 190

* Atlas Copco AB ATCOa.ST: Citigroup cuts target price to SEK 207 from SEK 212

* Barratt Redrow Plc BTRW.L: Morgan Stanley cuts target price to 580p from 600p

* Befesa BFSA.DE: Deutsche Bank cuts target price to EUR 28 from EUR 33

* Bureau Veritas BVI.PA: Deutsche Bank raises target price to EUR 30 from EUR 26

* Creo Medical Group Plc CREO.L: Deutsche Bank cuts target price to 45p from 80p

* Deutsche Bank DBKGn.DE: Morgan Stanley raises target price to EUR 20 from EUR 19.6

* Deutsche Boerse AG DB1Gn.DE: KBW raises target price to EUR 225 from EUR 217

* Dowlais Group Plc DWL.L: Citigroup cuts target price to 58p from 79p

* Dowlais Group Plc DWL.L: Citigroup raises to neutral from sell

* DS Smith SMDS.L: Jefferies raises target price to 550p from 400p

* DWS Group Gmbh & Co KGaA DWSG.DE: Citigroup raises PT to EUR 43 from EUR 42

* EDP EDP.LS: Deutsche Bank cuts target price to EUR 4.1 from EUR 4.2

* EDPR EDPR.LS: Deutsche Bank cuts target price to EUR 15 from EUR 16

* Handelsbanken SHBa.ST: Jefferies raises target price to SEK 101 from SEK 97

* Heineken NV HEIN.AS: Barclays cuts target price to EUR 90 from EUR 92

* Hunting HTG.L: Barclays cuts target price to 480p from 500p

* Kering PRTP.PA: Jefferies cuts target price to EUR 210 from EUR 220

* Kering PRTP.PA: JP Morgan cuts target price to EUR 220 from EUR 265

* Kering PRTP.PA: Morgan Stanley cuts target price to EUR 255 from EUR 265

* Kering PRTP.PA: RBC cuts target price to EUR 230 from EUR 280

* Kuehne & Nagel International AG KNIN.S: Barclays cuts PT to CHF 230 from CHF 250

* L'Oreal S.A OREP.PA: Morgan Stanley cuts target price to EUR 394 from EUR 430

* L'Oréal SA OREP.PA: Barclays cuts target price to EUR 442 from EUR 479

* Michelin MICP.PA: Barclays cuts target price to EUR 31 from EUR 32

* Michelin MICP.PA: Deutsche Bank cuts target price to EUR 37 from EUR 40

* Munters Group AB MTRS.ST: Jefferies cuts target price to SEK 230 from SEK 260

* Pennon Group PNN.L: Barclays cuts target price to 650p from 685p

* Planisware SA PLNW.PA: Citigroup cuts target price to EUR 30 from EUR 34

* Playtech PTEC.L: Deutsche Bank raises target price to 908p from 873p

* Quilter Plc QLT.L: Jefferies initiates coverage with buy rating; price target 175p

* Reckitt Benckiser RKT.L: Morgan Stanley raises target price to 4600p from 4500p

* Redeia REDE.MC: Citigroup raises target price to EUR 18.7 from EUR 18.6

* Rentokil RTO.L: Peel Hunt cuts target price to 367p from 380p

* Roche ROG.S: Deutsche Bank raises target price to CHF 250 from CHF 235

* Sampo SAMPO.HE: Deutsche Bank raises target price to EUR 42 from EUR 39

* Schindler Holding AG SCHP.S: RBC raises target price to CHF 270 from CHF 260

* Softcat Plc SCTS.L: JP Morgan raises target price to 1,350p from 1,250p

* Spectris SXS.L: HSBC cuts target price to 2900p from 3050p

* Spire Healthcare Group Plc SPI.L: Jefferies raises target price to 278p from 250p

* SSAB SSABa.ST: Deutsche Bank cuts target price to SEK 58 from SEK 60

* Swedbank SWEDa.ST: JP Morgan raises target price to SEK 215 from SEK 195

* Synthomer Plc SYNTS.L: Morgan Stanley cuts target price to 220p from 250p

* Temenos AG TEMN.S: Barclays raises target price to CHF 58 from CHF 56

* Temenos AG TEMN.S: Citigroup cuts target price to CHF 65 from CHF 66

* Verallia SA VRLA.PA: Citigroup cuts target price to EUR 39.5 from EUR 41.5

* Zalando SE ZALG.DE: Citigroup raises target price to EUR 37.5 from EUR 34


(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.